J Pediatr Genet 2023; 12(03): 219-223
DOI: 10.1055/s-0041-1726281
Case Report

Electroclinical Improvement in a Patient with Ring Chromosome 20 Syndrome Treated with Zonisamide: A Case Report

Stefano Parravicini
1   Department of Child Neurology and Psychiatry, IRCSS Mondino Foundation, European Reference Network for Rare and Complex Epilepsies, EpiCARE, Pavia, Italy
2   Brain and Behaviour Department, University of Pavia, Pavia, Italy
,
Ludovica Pasca
1   Department of Child Neurology and Psychiatry, IRCSS Mondino Foundation, European Reference Network for Rare and Complex Epilepsies, EpiCARE, Pavia, Italy
2   Brain and Behaviour Department, University of Pavia, Pavia, Italy
,
Martina Paola Zanaboni
1   Department of Child Neurology and Psychiatry, IRCSS Mondino Foundation, European Reference Network for Rare and Complex Epilepsies, EpiCARE, Pavia, Italy
,
Costanza Varesio
1   Department of Child Neurology and Psychiatry, IRCSS Mondino Foundation, European Reference Network for Rare and Complex Epilepsies, EpiCARE, Pavia, Italy
2   Brain and Behaviour Department, University of Pavia, Pavia, Italy
,
Elisa Rognone
3   Department of Neuroradiology, IRCSS Mondino Foundation, Pavia, Italy
,
Martina Totaro
1   Department of Child Neurology and Psychiatry, IRCSS Mondino Foundation, European Reference Network for Rare and Complex Epilepsies, EpiCARE, Pavia, Italy
2   Brain and Behaviour Department, University of Pavia, Pavia, Italy
,
Simone Gana
4   Medical Genetics, IRCCS Mondino Foundation, Pavia, Italy
,
Elena Rossi
4   Medical Genetics, IRCCS Mondino Foundation, Pavia, Italy
5   Department of Molecular Medicine, University of Pavia, Pavia, Italy
,
Valentina De Giorgis
1   Department of Child Neurology and Psychiatry, IRCSS Mondino Foundation, European Reference Network for Rare and Complex Epilepsies, EpiCARE, Pavia, Italy
› Author Affiliations
Funding This work was partially supported by Italian Ministry of Health (RC 2020–2022).

Abstract

Ring chromosome 20 or r(20) syndrome is a rare chromosomal disorder, mainly characterized by childhood-onset drug-resistant epilepsy with typical electroencephalographic findings, followed by mild to severe cognitive-behavioral decline. Recent studies support a possible role of the dopaminergic system in the epileptogenesis of this syndrome. We report the case of a 13-year-old female with mosaic r(20) who showed typical disease onset and evolution and a remarkable electroclinical improvement with zonisamide. Epilepsy related to r(20) is often medically intractable. When valproate and lamotrigine are not effective, zonisamide could be further investigated as a therapeutic option, since it acts as antifocal and it has a potential role in the prevention of dopamine depletion.

Note

The informed consent for this case report to be published was provided by the legal tutors of the patient.


Authors' Contributions

S.P., L.P., C.V., and M.P.Z. conceptualized the study, drafted the original manuscript, and critically reviewed and edited the manuscript. C.V., E.R., M.T., and S.G. involved in investigation of the study. V.D.G. supported in conceptualization and also carried out the supervision of study.


Supplementary Material



Publication History

Received: 24 July 2020

Accepted: 06 February 2021

Article published online:
01 April 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Elens I, Vanrykel K, De Waele L. et al. Ring chromosome 20 syndrome: electroclinical description of six patients and review of the literature. Epilepsy Behav 2012; 23 (04) 409-414
  • 2 Vignoli A, Bisulli F, Darra F. et al. Epilepsy in ring chromosome 20 syndrome. Epilepsy Res 2016; 128: 83-93
  • 3 Gago-Veiga AB, Toledano R, Garcia-Morales I, Perez-Jimenez M, Bernar J, Gil-Nagel A. Specificity of electroclinical features in the diagnosis of ring chromosome 20. Epilepsy Behav 2018 80. 215-220
  • 4 Vignoli A, Canevini MP, Darra F. et al. Ring chromosome 20 syndrome: a link between epilepsy onset and neuropsychological impairment in three children. Epilepsia 2009; 50 (11) 2420-2427
  • 5 Kurahashi H, Wang JW, Ishii A. et al. Deletions involving both KCNQ2 and CHRNA4 present with benign familial neonatal seizures. Neurology 2009; 73 (15) 1214-1217
  • 6 Conlin LK, Kramer W, Hutchinson AL. et al. Molecular analysis of ring chromosome 20 syndrome reveals two distinct groups of patients. J Med Genet 2011; 48 (01) 1-9
  • 7 Del Sole A, Chiesa V, Lucignani G. et al. Exploring dopaminergic activity in ring chromosome 20 syndrome: a SPECT study. Q J Nucl Med Mol Imaging 2010; 54 (05) 564-569
  • 8 Walleigh DJ, Legido A, Valencia I. Ring chromosome 20: a pediatric potassium channelopathy responsive to treatment with ezogabine. Pediatr Neurol 2013; 49 (05) 368-369
  • 9 Onder H, Tezer FI. Significant improvements of EEG and Clinical Findings with oral lacosamide in a patient with Ring Chromosome 20. Clin EEG Neurosci 2016; 47 (04) 330-332
  • 10 Parr JR, Pang K, Mollett A. et al. Epilepsy responds to vagus nerve stimulation in ring chromosome 20 syndrome. Dev Med Child Neurol 2006; 48 (01) 80 , author reply 80
  • 11 De Giorgis V, Filippini M, Macasaet JA, Masnada S, Veggiotti P. Neurobehavioral consequences of continuous spike and waves during slow sleep (CSWS) in a pediatric population: a pattern of developmental hindrance. Epilepsy Behav 2017; 74: 1-9
  • 12 Ikeda K, Yanagihashi M, Miura K. et al. Zonisamide cotreatment delays striatal dopamine transporter reduction in Parkinson disease: a retrospective, observational cohort study. J Neurol Sci 2018; 391: 5-9